ProfileGDS4718 / 242389_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 82% 82% 81% 82% 87% 83% 79% 78% 81% 76% 76% 89% 75% 80% 77% 65% 73% 79% 80% 96% 81% 75% 77% 78% 82% 78% 83% 87% 84% 89% 66% 76% 82% 76% 77% 75% 87% 82% 80% 80% 76% 84% 74% 73% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.1328182
GSM549102patient 115, normal, homogenized [OPG study]8.025982
GSM549104patient 119, normal, homogenized [OPG study]8.0616481
GSM549108patient 138, normal, homogenized [OPG study]7.9899382
GSM549119patient 077, normal, homogenized [OPG study]8.6570887
GSM549133patient 032, cancer, homogenized [OPG study]8.3126583
GSM549139patient 042, cancer, homogenized [OPG study]7.769779
GSM549099patient 107, normal, homogenized [OPG study]7.6070378
GSM549109patient 139, normal, homogenized [OPG study]7.894981
GSM549110patient 046, normal, homogenized [OPG study]7.373976
GSM549114patient 063, normal, homogenized [OPG study]7.5120776
GSM549122patient 082, normal, homogenized [OPG study]9.0306889
GSM549134patient 033, cancer, homogenized [OPG study]7.3019475
GSM549136patient 036, cancer, homogenized [OPG study]7.9587280
GSM549140patient 044, cancer, homogenized [OPG study]7.6618477
GSM549111patient 047, normal, homogenized [OPG study]6.5112565
GSM549113patient 057, normal, homogenized [OPG study]7.1326973
GSM549132patient 031, cancer, homogenized [OPG study]7.7691579
GSM549137patient 038, cancer, homogenized [OPG study]7.8525580
GSM549142patient 047, cancer, homogenized [OPG study]9.9247196
GSM549100patient 110, normal, homogenized [OPG study]7.8471181
GSM549107patient 135, normal, homogenized [OPG study]7.3826975
GSM549115patient 068, normal, homogenized [OPG study]7.6670577
GSM549116patient 072, normal, homogenized [OPG study]7.7313378
GSM549120patient 078, normal, homogenized [OPG study]8.0379482
GSM549131patient 030, cancer, homogenized [OPG study]7.7416978
GSM549118patient 074, normal, homogenized [OPG study]8.2349783
GSM549129patient 027, cancer, homogenized [OPG study]8.7136287
GSM549123patient 088, normal, homogenized [OPG study]8.3230484
GSM549124patient 006, cancer, homogenized [OPG study]8.9434689
GSM549126patient 015, cancer, homogenized [OPG study]6.557566
GSM549128patient 025, cancer, homogenized [OPG study]7.5564276
GSM549103patient 117, normal, homogenized [OPG study]7.9070382
GSM549117patient 073, normal, homogenized [OPG study]7.3822476
GSM549138patient 041, cancer, homogenized [OPG study]7.5969577
GSM549141patient 045, cancer, homogenized [OPG study]7.4975975
GSM549130patient 028, cancer, homogenized [OPG study]8.6902787
GSM549101patient 111, normal, homogenized [OPG study]8.030382
GSM549105patient 128, normal, homogenized [OPG study]7.8087980
GSM549106patient 134, normal, homogenized [OPG study]8.027880
GSM549112patient 048, normal, homogenized [OPG study]7.4184976
GSM549125patient 011, cancer, homogenized [OPG study]8.2626784
GSM549127patient 024, cancer, homogenized [OPG study]7.2931974
GSM549135patient 035, cancer, homogenized [OPG study]7.2563473